Literature DB >> 2989729

Behavioural effects in rats of unilateral and bilateral injections of opiate receptor agonists into the globus pallidus.

D Dewar, P Jenner, C D Marsden.   

Abstract

Unilateral injections of a putative kappa-opiate receptor agonist, ethylketocyclazocine, into the globus pallidus of rats caused dose-dependent ipsiversive circling which was inhibited by prior systemic administration of the opiate receptor antagonist naloxone. Neither a putative delta-opiate receptor agonist ( [D-Ala2, D-Leu5]enkephalin) nor a putative mu-opiate receptor agonist (Tyr-D-Ala-Gly-MePhe-Met(0)-ol) induced circling behaviour after unilateral intrapallidal injection. Bilateral intrapallidal injection of the delta-opiate receptor agonist or the mu-opiate receptor agonist caused an increase in locomotor activity which in both cases was reduced by systemic administration of naloxone. A specific delta-receptor antagonist, (N,N-bisalyl-Tyr-Gly-Gly-psi-(CH2S)-Phe-Leu-OH) had no effect on the increase in locomotor activity caused by the delta-opiate receptor agonist. Bilateral intrapallidal injection of the kappa-opiate receptor agonist had no effect on locomotor activity. It is suggested that different opiate receptor subtypes within the globus pallidus differentially mediate circling and locomotor behaviour.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989729     DOI: 10.1016/0306-4522(85)90121-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  2 in total

1.  Microdialysis and mass spectrometric monitoring of dopamine and enkephalins in the globus pallidus reveal reciprocal interactions that regulate movement.

Authors:  Omar S Mabrouk; Qiang Li; Peng Song; Robert T Kennedy
Journal:  J Neurochem       Date:  2011-05-25       Impact factor: 5.372

2.  Endomorphin-1: induction of motor behavior and lack of receptor desensitization.

Authors:  A Mehta; G Bot; T Reisine; M F Chesselet
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.